ANNALYSA ELIZONDO: Open Payments
NPI 1831868942 · SCHERTZ, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 20 payments from 8 companies in 2025. Trend: 2023 $2,121 · 2024 $541 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $150 |
| GlaxoSmithKline, LLC. | 11 | $141 |
| ABBVIE INC. | 3 | $54 |
| Tactile Systems Technology Inc | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $15 |
| United Therapeutics Corporation | 1 | $14 |
Products named: CARDIOMEMS, NUCALA, TRELEGY ELLIPTA, Flexitouch Plus, JASCAYD, Dexcom G6 Transmitter, LINZESS, UBRELVY.
Industry payments across TX — which companies pay providers there.
